DeutschNewstral
Article
bizjournals.com on 2019-04-09 11:46
Report: Life sciences VC slows in Q1, but tech deals still strong
Related news
- MVC investing remains strong for Midwest life sciences firmsmibiz.com
U.S. GDP Slows in Q1 But Shows Strong Consumer Spendingjdsupra.com- Report: VC fundraising has ‘rocky period’ ahead, despite strong Q1bizjournals.com
- A review of Triangle VC deals in first half of 2019 reveals 'robust' life sciences activitybizjournals.com
- 2020 in Review: Philadelphia-area life sciences firms land more than $530M in VC dealsbizjournals.com
- SwanBio raises $56M despite 'bearish' market for life sciences VC dealsbizjournals.com
- Local VC deals slow in Q1. Here’s what’s next for investment.bizjournals.com
Here’s the 6 biggest crypto VC deals in Q1 2024 and late 2023cointelegraph.com- These are the top Mass. tech VC deals in 2019's Q1bizjournals.com
- Q1 VC deals kept pace with last year — but exits were downbizjournals.com
- VC deals top $1.3B in Massachusetts during Q1 2015 (BBJ slide show)bizjournals.com
- St. Louis VC investment down in Q1 following strong 2018 totals: Reportsbizjournals.com
- Latest VC data shows strong Q1, but COVID-19 uncertainty looms moving forwardbizjournals.com
- Central Florida’s Autism Impact Fund flush with cash and looking for deals even as VC industry slowsbizjournals.com
- Atlanta Inno: Startups close Q1 strong, deals expected to slow due to COVID-19bizjournals.com
- Roper's pipeline for M&A remains strong despite no Q1 deals, CEO saysbizjournals.com
European VC soars in Q1TechCrunch- LBig Deals Q1 2019lawweekcolorado.com
- Life Sciences Legal Update - Q1 2022jdsupra.com
- Life Sciences Legal Update - Q1 2023 (Czech)jdsupra.com